Back

Integrated clonal analysis reveals circulating tumor DNA in urine and plasma of glioma patients

Mouliere, F.; Heider, K.; Smith, C. G.; Su, J.; Thompson, M.; Morris, J.; Wan, J. C. M.; Chandrananda, D.; Hadfield, J.; Grezlak, M.; Hudecova, I.; Cooper, W.; Gale, D.; Eldridge, M.; Watts, C.; Brindle, K.; Rosenfeld, N.; Mair, R.

2019-09-11 genomics
10.1101/758441 bioRxiv
Show abstract

Glioma-derived cell-free tumor DNA is challenging to detect using standard liquid biopsy techniques as its levels in body fluids are very low, similar to those in patients with early stage carcinomas. By sequencing cell-free DNA across thousands of clonal and private mutations identified individually in each patients tumor we detected tumor-derived DNA in plasma (10/12, 83%) and urine samples (8/11, 72%) from the majority (7/8, 87.5%) of glioma patients tested.\n\nOne Sentence SummaryCirculating tumor DNA can be detected in the majority of plasma and urine samples from primary brain tumor patients using sequencing guided by mutations detected in multi-region tumor biopsies.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.